Assessing the applicability of obstetrical randomized controlled trials in real-world practices

Area of Science:

• Obstetrics and Gynecology
• Clinical Trial Methodology
• Evidence-Based Medicine

Background:

• Randomized controlled trials (RCTs) are the gold standard for medical evidence.
• The real-world applicability of obstetrical RCTs is crucial for sustainable healthcare practices.
• Assessing the value of RCTs requires evaluating their potential for real-world implementation and impact.

Purpose of the Study:

• To examine the real-world applicability of obstetrical randomized controlled trials (RCTs).
• To propose a classification system for the value of RCTs based on their potential for achieving sustainable practices.
• To provide guidance for designing and evaluating obstetrical RCTs.

Main Methods:

• Analysis of notable obstetrical randomized controlled trials (RCTs).
• Evaluation of trial definitions for diagnosis (study group characteristics) and treatment (intervention).
• Assessment of the clarity, specificity, and implementability of trial parameters.

Main Results:

• RCTs with well-defined diagnoses and treatments that do not require specialized expertise yield higher real-world value.
• Trials with ambiguous or undefined diagnoses and treatments result in practice variations and unreliable outcomes.
• Pragmatic trials' real-world implementation is influenced by the clarity of diagnostic and treatment definitions.

Conclusions:

• The clarity and specificity of diagnostic and treatment definitions significantly impact the real-world value and sustainability of obstetrical RCTs.
• RCTs with clear, broadly applicable interventions are more likely to translate into effective healthcare practices and policies.
• Recognizing the variability in RCT design and definitions is essential for improving their relevance and impact in obstetrics.